Last update :
29/10/2024
Various   Neostigmine methylsulfate  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adwigmine Egypt
Amostigmine Egypt
Beemine India
Bloxiverz
Epistigmine Egypt
Fadastigmina Argentina, Italy, Portugal
Ipostigmine Iran
Miostin Romania
Neostig Germany
Neostigmin Germany, Sweden
Neostigmina Argentina, Chile, Colombia, Ecuador, Peru, Portugal, Spain, Venezuela
Neostigmine Australia, Canada, Egypt, Great Britain, Greece, Ireland, Malaysia, Netherlands, New Zealand, Saudi Arabia, Turkey
Neostigmine methylsulfate Canada
Neostigten Peru
Normastigmin Austria
Planstigmin Turkey
Polstigminum Poland
Prostigmin Austria, Belgium, Greece, Malaysia, Netherlands, Switzerland
Prostigmina Italy
Prostigmine Belgium, Chile, Colombia, Egypt, France, Luxembourg, Mexico, Morocco, Spain, United Arab Emirates, Venezuela
Setisin Malaysia
Stigmosan Hungary
Tigmin Peru
Visulmin Mexico
Compatibility   injection   Compatibility : Neostigmine methylsulfate              
This screen indicates the compatibilities or incompatibilities with, in this case, the type of incompatibility (precipitation, color change, modification of an emulsion, etc.). The compatibilities shown here are mostly physical only, with the chemical stability of each molecule rarely being assessed. The evaluation of these mixtures was studied to consider the possibility of Y-site administration to the patient. These data cannot be used for making mixtures in advance in bags or syringes. This type of information is available in the screen "Stability in mixture ».
Compound Solvent References
Unspecified incompatibility Incompatible
injection Neostigmine methylsulfate
injection Calcium gluconate
3644
Chemical instability Incompatible
injection Neostigmine methylsulfate
injection Cisplatin
3578
Compatible
injection Neostigmine methylsulfate
injection Glycopyrronium bromide
3599
Compatible
injection Neostigmine methylsulfate 0,5 mg/ml
injection Glycopyrronium bromide 0,2 mg/ml
None 2286
Compatible
injection Neostigmine methylsulfate 0.5 mg/ml
injection Heparin sodium 1 UI/ml
NaCl 0,9% or Glucose 5% 1228
Compatible
injection Neostigmine methylsulfate 0.5 mg/ml
injection Heparin sodium 1 UI/ml
Ringer’s lactate solution 1228
Compatible
injection Neostigmine methylsulfate 0.5 mg/ml
injection Hydrocortisone sodium succinate 1 mg/ml
NaCl 0,9% or Glucose 5% 1228
Compatible
injection Neostigmine methylsulfate 0.5 mg/ml
injection Hydrocortisone sodium succinate 1 mg/ml
Ringer’s lactate solution 1228
Compatible
injection Neostigmine methylsulfate 0.04 mg/ml
injection Netilmicin sulfate 3 mg/ml
NaCl 0,9% or Glucose 5% 1200
Compatible
injection Neostigmine methylsulfate 0.167 mg/ml
injection Ondansetron hydrochloride 1.33 mg/ml
Sodium chloride 0,9% 815
Compatible
injection Neostigmine methylsulfate 0,5 mg/ml
injection Palonosetron hydrochloride 50 µg/ml
None 2286
Compatible
injection Neostigmine methylsulfate 0.5 mg/ml
injection Potassium chloride 40 mEq/l
NaCl 0,9% or Glucose 5% 1228
Compatible
injection Neostigmine methylsulfate 0.5 mg/ml
injection Potassium chloride 40 mEq/l
Ringer’s lactate solution 1228
Compatible
injection Neostigmine methylsulfate 0.5 mg/ml
injection Sugammadex 100 mg/ml
None 3372

  Mentions Légales